Volpara Health Technologies Ltd
ASX:VHT
Volpara Health Technologies Ltd
Research & Development
Volpara Health Technologies Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Volpara Health Technologies Ltd
ASX:VHT
|
Research & Development
-NZ$16.4m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
Volpara Health Technologies Ltd
Glance View
Volpara Health Technologies Ltd. engages in selling the VolparaEnterprise software, which is a cloud-based breast imaging analytics product. The firm is engaged in developing digital health solutions to enable personalized breast cancer screening based on objective measurements of breast density, compression, and radiation dose. Its geographic segments include North America, Europe, the Middle East and Africa (EMEA), Asia-Pacific (APAC), and Corporate. The firm's offerings include VolparaEnterprise, which enables breast imaging providers to perform control checks; VolparaDensity, which provides objective assessment of a woman's breast density; VolparaRisk is a software that features a patient questionnaire; VolparaLive provides technologists with real-time decision support at the point of care to assess image quality, and Aspen Brest, which is a workflow software that optimizes operations and administration for breast cancer screening programs.
See Also
What is Volpara Health Technologies Ltd's Research & Development?
Research & Development
-16.4m
NZD
Based on the financial report for Sep 30, 2023, Volpara Health Technologies Ltd's Research & Development amounts to -16.4m NZD.
What is Volpara Health Technologies Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-29%
Over the last year, the Research & Development growth was 13%. The average annual Research & Development growth rates for Volpara Health Technologies Ltd have been -7% over the past three years , -29% over the past five years .
